These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1393 related articles for article (PubMed ID: 27783843)

  • 1. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Tsoulis DJ; MacDonald JK
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Wang Y; Tsoulis DJ; MacDonald JK; Feagan BG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003459. PubMed ID: 25099640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Chande N; Patton PH; Tsoulis DJ; Thomas BS; MacDonald JK
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD000067. PubMed ID: 26517527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Taylor K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Wang Y; MacDonald JK; Hanauer S
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A; McDonald JW; Tsoulis DJ; Macdonald JK
    Cochrane Database Syst Rev; 2012 Sep; (9):CD000478. PubMed ID: 22972046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A; Patton PH; Chande N; McDonald JW; MacDonald JK
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD000478. PubMed ID: 27192092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Wang Y; MacDonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006884. PubMed ID: 25157445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2010 Jun; (6):CD000545. PubMed ID: 20556747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.
    Boyapati RK; Torres J; Palmela C; Parker CE; Silverberg OM; Upadhyaya SD; Nguyen TM; Colombel JF
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012540. PubMed ID: 29756637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab for maintenance of remission in Crohn's disease.
    Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral nutrition for maintenance of remission in Crohn's disease.
    Akobeng AK; Zhang D; Gordon M; MacDonald JK
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005984. PubMed ID: 30098021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.